Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
About this item
Full title
Author / Creator
Kimball, Alexa B , Okun, Martin M , Williams, David A , Gottlieb, Alice B , Papp, Kim A , Zouboulis, Christos C , Armstrong, April W , Kerdel, Francisco , Gold, Michael H , Forman, Seth B , Korman, Neil J , Giamarellos-Bourboulis, Evangelos J , Crowley, Jeffrey J , Lynde, Charles , Reguiai, Ziad , Prens, Errol-Prospero , Alwawi, Eihab , Mostafa, Nael M , Pinsky, Brett , Sundaram, Murali , Gu, Yihua , Carlson, Dawn M and Jemec, Gregor B.E
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
Hidradenitis suppurativa is a painful, chronic inflammatory skin disease. In two double-blind, placebo-controlled trials, treatment with adalimumab resulted in significantly increased rates of clinical response at week 12. Rates of serious adverse events were similar between groups.
Hidradenitis suppurativa, also known as acne inversa, is a pain...
Alternative Titles
Full title
Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
Authors, Artists and Contributors
Author / Creator
Okun, Martin M
Williams, David A
Gottlieb, Alice B
Papp, Kim A
Zouboulis, Christos C
Armstrong, April W
Kerdel, Francisco
Gold, Michael H
Forman, Seth B
Korman, Neil J
Giamarellos-Bourboulis, Evangelos J
Crowley, Jeffrey J
Lynde, Charles
Reguiai, Ziad
Prens, Errol-Prospero
Alwawi, Eihab
Mostafa, Nael M
Pinsky, Brett
Sundaram, Murali
Gu, Yihua
Carlson, Dawn M
Jemec, Gregor B.E
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1809588340
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1809588340
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1504370
